Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kohl

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Die Medizinische Welt|December 24, 1982
["Yes--it is a drug"]E Kohl
Annals of the New York Academy of Sciences|February 10, 2000
Farnesyltransferase inhibitors. Preclinical developmentN E Kohl
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 16, 2013
[New developments in photodynamic therapy]E Kohl, S Karrer
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 19, 2011
Photodynamic therapy for photorejuvenation and non-oncologic indications: overview and updateE Kohl, S Karrer
Annual Review of Genomics and Human Genetics|March 20, 2026
Organoid Perturbations as Tools to Explore Cellular Function and PlasticityKatharina E Kohl, Georg A Busslinger
Oncogene|January 1, 1987
Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenesN E Kohl, H E Ruley
Cancer Metastasis Reviews|October 14, 1998
Pre-clinical development of farnesyltransferase inhibitorsR B Lobell, N E Kohl
Journal of Travel Medicine|March 19, 2016
Twitter for travel medicine providersDeborah J Mills, Sarah E Kohl
Trends in Pharmacological Sciences|January 14, 1998
CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agentsC A Omer, N E Kohl
Travel Medicine and Infectious Disease|June 25, 2019
What do we know about travel for children with special health care needs? A review of the literatureSarah E Kohl, Elizabeth D Barnett
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Die Medizinische Welt|December 24, 1982
["Yes--it is a drug"]E Kohl
Annals of the New York Academy of Sciences|February 10, 2000
Farnesyltransferase inhibitors. Preclinical developmentN E Kohl
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 16, 2013
[New developments in photodynamic therapy]E Kohl, S Karrer
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 19, 2011
Photodynamic therapy for photorejuvenation and non-oncologic indications: overview and updateE Kohl, S Karrer
Annual Review of Genomics and Human Genetics|March 20, 2026
Organoid Perturbations as Tools to Explore Cellular Function and PlasticityKatharina E Kohl, Georg A Busslinger
Oncogene|January 1, 1987
Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenesN E Kohl, H E Ruley
Cancer Metastasis Reviews|October 14, 1998
Pre-clinical development of farnesyltransferase inhibitorsR B Lobell, N E Kohl
Journal of Travel Medicine|March 19, 2016
Twitter for travel medicine providersDeborah J Mills, Sarah E Kohl
Trends in Pharmacological Sciences|January 14, 1998
CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agentsC A Omer, N E Kohl
Travel Medicine and Infectious Disease|June 25, 2019
What do we know about travel for children with special health care needs? A review of the literatureSarah E Kohl, Elizabeth D Barnett
Pageof 13